Hyperandrogenism
Showing NaN - NaN of 5
Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Spironolactone, Placebo)
Recruiting
- Hyperandrogenism
- +2 more
- Spironolactone
- Placebo
-
Charlottesville, VirginiaCenter for Research in Reproduction, University of Virginia
Jul 28, 2022
Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Micronized progesterone, Spironolactone, Placebo)
Recruiting
- Hyperandrogenism
- +2 more
- Micronized progesterone
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia Clinical Research Unit
May 16, 2022
Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Suspended
- Polycystic Ovary Syndrome
- +2 more
- Phenotype/genotype assessment
-
Charlottesville, VirginiaCenter for Research in Reproduction
May 16, 2022
Polycystic Ovary Syndrome, Hyperandrogenism Trial in Charlottesville (Metformin, Progesterone, estrace)
Completed
- Polycystic Ovary Syndrome
- Hyperandrogenism
- Metformin
- +2 more
-
Charlottesville, VirginiaCenter for Research in Reproduction, University of Virginia
Dec 14, 2020
Polycystic Ovary Syndrome, Hyperandrogenism Trial in Charlottesville (Flutamide, Progesterone, estrace)
Terminated
- Polycystic Ovary Syndrome
- Hyperandrogenism
- Flutamide
- +2 more
-
Charlottesville, VirginiaCenter for Research in Reproduction, University of Virginia
May 1, 2018